B-Dmd KO(del45-50) mice

C57BL/6JNifdc-Dmdtm1(Dmd Exon45-50 del) /Bcgen • 113915

B-Dmd KO(del45-50) mice

Product nameB-Dmd KO(del45-50) mice
Catalog number113915
Strain nameC57BL/6JNifdc-Dmdtm1(Dmd Exon45-50 del) /Bcgen
Strain backgroundC57BL/6JNifdc
NCBI gene ID13405 (Mouse)
Aliasesdys; mdx; pke; Dp71; Dp427; DXSmh7; DXSmh9

이 페이지에서

  • Description
  • Targeting strategy
  • Phenotypic analysis

포스터

모두 보기

    출판물

      Description
      • Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and premature death.
      • Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene. These mutations frequently entail deletions of one or more exons, which disrupt the open reading frame and introduce a premature stop codon. This leads to the production of a nonfunctional truncated dystrophin protein, resulting in a severe muscle degeneration phenotype.
      • The exons 45-50 of mouse Dmd gene were deleted in B-Dmd KO(del45-50) mice.
      • Mouse Dmd mRNA and DMD protein were detectable in wild-type C57BL/6JNifdc mice but not in homozygous B-Dmd KO(del45-50) mice.
      • This product is used for pharmacodynamics of Duchenne muscular dystrophy.
      Targeting strategy

      Gene targeting strategy for B-Dmd KO(del45-50) mice. The exons 45-50 of mouse Dmd gene were deleted in B-Dmd KO(del45-50) mice.

      mRNA expression analysis

      Strain specific analysis of DMD mRNA expression in wild-type C57BL/6JNifdc mice and B-Dmd KO(del45-50) mice by RT-PCR. Heart and skeletal muscle RNA were isolated from wild-type C57BL/6JNifdc mice (+/+) and homozygous B-Dmd KO(del45-50) mice (H/Y), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse Dmd primers. Dmd mRNA was detectable in wild-type C57BL/6JNifdc mice (+/+) but not the homozygous B-Dmd KO(del45-50) mice (-/Y).

      Protein expression analysis

      Western blot analysis of DMD protein expression in B-Dmd KO(del45-50) mice. Various tissue lysates were collected from wild-type C57BL/6JNifdc mice (+/+) and B-Dmd KO(del45-50) mice (-/Y), and then analyzed by western blot with anti-Dystrophin antibody (Sigma, D8168). 50 μg total proteins were loaded for western blotting analysis. DMD was detectable in heart, skeletal muscle and skin from wild-type C57BL/6JNifdc mice (+/+) but not homozygous B-Dmd KO(del45-50) mice (-/Y).

      Behavioral performance analysis

      Behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice. Grip strength tests were conducted to assay the behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice (male, 5-month-old, n=9). Grip strength results showed the strength produced by forelimb was ~20 N/kg in homozygous B-Dmd KO(del45-50) mice, which was significant weaker than that in wild-type control mice. All grip strength measurements are normalized to the individual animal’s body weight. Values are expressed as mean ± SEM. Significance was determined by unpaired t test.  *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

      Behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice. Rotarod tests were conducted to assay the behavioral performance in wild-type C57BL/6JNifdc and homozygous B-Dmd KO(del45-50) mice (male, 5-month-old, n=9). Rotarod tests were performed to assay the motor coordination. The latency to fall, rodspeed and total distance were significantly decreased in homozygous B-Dmd KO(del45-50) mice, showing the impairment of motor coordination and balance. Values are expressed as mean ± SEM. Significance was determined by unpaired t test.  *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.